Arkolith/Insider Trading/INBX/Form 4

Lappe Mark

Chief Executive Officer, DirectorInhibrx Biosciences, Inc. (INBX) · full profile →Form 4 · filed Sep 3, 2024
Net Buying
Open-Market Buys
$597K
Open-Market Sells
$0
Net Open-Market Flow
$597K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 3, 2024Buy(P)5K$16.31$77K165K
Sep 3, 2024Buy(P)15K$15.66$239K160K
Aug 30, 2024Buy(P)10K$14.02$140K145K
Aug 29, 2024Buy(P)10K$14.03$140K135K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001739614-24-000037) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML